Table 2.

Serum tumor marker, VEGF, NO and ANG II levels of the patients at baseline and at the end of 6^th cycle of therapy.

	Baseline (median, min–max)	At the end of 6th cycle (median, min–max)
VEGF	197.7 (8.2–681.6)	87.1 (12.4–141.2)	P=0.009
NO	6.32 (2.5–21.5)	6.7 (2.9–28.9)
ANG II	4.51 (1.2–10.8)	3.55 (1.58–8.9)